With platform technologies in chemotherapy and immunotherapy, and RNAi engineered to enhance the benefits of proven agents, our mission is transformational.
Location: United States, New Jersey, Lawrence Township
Employees: 11-50
Founded date: 1985
Investors 2
| Date | Name | Website |
| 06.11.2022 | Hercules C... | htgc.com |
| - | Horizon Te... | horizontec... |
Mentions in press and media 13
| Date | Title | Description |
| 31.03.2022 | Celsion Corporation Partners with Mediaplanet to Increase Awareness in Ovarian Cancer Clinical Research | “Celsion Corporation understands that volunteering for a clinical research study can be a difficult decision. We have created a patient-friendly website to answer questions and help patients understand more about our OVATION 2 study” NEW YO... |
| 28.02.2022 | Celsion Receives $1.4 Million from Sale of its New Jersey State Net Operating Losses | Non-dilutive funding further strengthens balance sheet and extends current operating runway through 2024 Additional $3.5 million of unused state NOLs expected to be sold in future years LAWRENCEVILLE, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) --... |
| 14.01.2022 | Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock | LAWRENCEVILLE, N.J., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced the closing of its previously a... |
| 14.01.2022 | Celsion : Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock - Form 8-K | Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock LAWRENCEVILLE, N.J., January 13, 2022 - Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focu... |
| 13.01.2022 | Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock | LAWRENCEVILLE, N.J., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced the closing of its previously a... |
| 12.01.2022 | Celsion : Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock - Form 8-K | Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock LAWRENCEVILLE, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) - Celsion Corporation (NASDAQ: CLSN), a clinical-stage developmen... |
| 11.01.2022 | Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock | LAWRENCEVILLE, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that it has entered into a secu... |
| 10.01.2022 | Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock | LAWRENCEVILLE, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that it has entered into a secu... |
| 16.06.2021 | Slone Partners Places Stacy R. Lindborg and Christine Pellizzari on Board of Directors at Celsion Corporation | “Both Stacy Lindborg and Christine Pellizzari are highly respected and influential leaders in the industry with more than 45 years of combined experience across a broad spectrum of roles and organizations,” said Slone Partners CEO Leslie Lo... |
| 11.05.2021 | CELSION CORPORATION Celsion : Receives $1.85 Million from the Sale of its New Jersey State Net Operating Losses | Non-Dilutive Funding Strengthens Balance Sheet, Extends Cash Runway Beyond 2024 Sale of an Additional $5.0 Million of State NOLs Expected in Future Years LAWRENCEVILLE, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLS... |
Show more